Article Details

Albireo Pharma (NASDAQ:ALBO) Receives “Buy” Rating from HC Wainwright

Retrieved on: 2019-08-19 20:45:00

Tags for this article:

Click the tags to see associated articles and topics

Albireo Pharma (NASDAQ:ALBO) Receives “Buy” Rating from HC Wainwright. View article details on hiswai:

Excerpt

<div>A number of hedge funds and other institutional investors have recently modified their holdings of ALBO. <b>Man Group plc</b> lifted its holdings in Albireo ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up